Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 4/20 | 1.00 |
| ▸ | MET | P08581 | 10/20 | 0.83 |
| ▸ | CA12 | O43570 | 3/20 | 0.83 |
| ▸ | CA4 | P22748 | 3/20 | 0.83 |
| ▸ | CA6 | P23280 | 3/20 | 0.83 |
| ▸ | CA5A | P35218 | 3/20 | 0.83 |
| ▸ | CA7 | P43166 | 3/20 | 0.83 |
| ▸ | CA9 | Q16790 | 3/20 | 0.83 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.83 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.83 |
| ▸ | HTR7 | P34969 | 1/20 | 0.83 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.76 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.76 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 1/20 | 0.76 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14259660 | 1.00 | TTR (1.00) | TTRMETCA12CA4CA6 | |
| SCHEMBL20914956 | 0.93 | TTR (0.87) | TTRMETCA12CA4CA6 | |
| SCHEMBL29009245 | 0.93 | TTR (0.87) | TTRMETCA12CA4CA6 | |
| SCHEMBL29009246 | 0.92 | TTR (0.85) | TTRMETCA12CA4CA6 | |
| SCHEMBL20914958 | 0.91 | TTR (1.00) | TTRMETCA12CA4CA6 | |
| SCHEMBL12298709 | 0.91 | MET (1.00) | TTRMETCA12CA4CA6 | |
| SCHEMBL28150502 | 0.91 | MET (1.00) | TTRMETCA12CA4CA6 | |
| SCHEMBL14113938 | 0.90 | TTR (1.00) | TTRMETCA12CA4CA6 | |
| SCHEMBL14432078 | 0.89 | MET (0.85) | TTRMETCA12CA4CA6 | |
| SCHEMBL15095873 | 0.89 | MET (0.85) | TTRMETCA12CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114636779-B | Construction method of three-conversion soup reference sample freeze-dried powder fingerprint and fingerprint thereof | 陕西盘龙药业集团股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-113759045-B | Characteristic spectrum of notopterygium root decoction pieces or formula granules, construction method of characteristic spectrum, notopterygium root formula granules, preparation method of notopterygium root formula granules and quality control method of notopterygium root formula granules | 北京康仁堂药业有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-114636779-A | Method for constructing sanhua decoction reference sample freeze-dried powder fingerprint spectrum and fingerprint spectrum thereof | 陕西科技大学 | 2022-06-17 | — | — | CN | claimed |
| CN-109828052-B | Method for rapidly identifying species, authenticity or existence of notopterygium root | 西南民族大学 | 2022-03-18 | — | — | CN | claimed |
| CN-113759045-A | Characteristic spectrum of notopterygium root decoction pieces or formula granules, construction method of characteristic spectrum, notopterygium root formula granules, preparation method of notopterygium root formula granules and quality control method of notopterygium root formula granules | 北京康仁堂药业有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-109828052-A | A kind of quick identification Rhizoma Et Radix Notopterygii type, the true and false or whether there is or not method | 西南民族大学 | 2019-05-31 | — | — | CN | claimed |
| CN-114636779-B | Construction method of three-conversion soup reference sample freeze-dried powder fingerprint and fingerprint thereof | 陕西盘龙药业集团股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-116242935-B | Construction method of characteristic patterns of notopterygium root or notopterygium latifolium and identification method thereof | 广东一方制药有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-116242935-A | Construction method of characteristic patterns of notopterygium root or notopterygium latifolium and identification method thereof | 广东一方制药有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-116179509-A | Method for synthesizing phenyl acrylate by feruloyl esterase catalysis | 广西大学 | 2023-05-30 | — | — | CN | disclosed |
| CN-113759045-B | Characteristic spectrum of notopterygium root decoction pieces or formula granules, construction method of characteristic spectrum, notopterygium root formula granules, preparation method of notopterygium root formula granules and quality control method of notopterygium root formula granules | 北京康仁堂药业有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-112798721-B | Fingerprint construction method and application of traditional Chinese medicine preparation for treating cervical spondylosis | 山东明仁福瑞达制药股份有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-114636779-A | Method for constructing sanhua decoction reference sample freeze-dried powder fingerprint spectrum and fingerprint spectrum thereof | 陕西科技大学 | 2022-06-17 | — | — | CN | disclosed |
| CN-109248265-A | Traditional Chinese medicine composition for treating breast cancer | 浏阳市利美免疫力修复中心有限公司 | 2019-01-22 | — | — | CN | disclosed |
| CN-105944070-A | Medicine preparation for treating intensive care respiratory system infection and preparation method thereof | 姚鲁肃 | 2016-09-21 | — | — | CN | disclosed |
| CN-102727761-B | Medicine for treating alopecia seborrheica and preventing hair drying and bifurcating and method for preparing medicine | ZHENGZHOU ZHANGGUANG101 HAIR GROWING TECHNOLOGY CO LTD | 2013-11-27 | — | — | CN | disclosed |
| CN-102727761-A | Medicine for treating alopecia seborrheica and preventing hair drying and bifurcating and method for preparing medicine | ZHENGZHOU ZHANGGUANG101 HAIR GROWING TECHNOLOGY CO LTD | 2012-10-17 | — | — | CN | disclosed |
| US-20100168228-A1 | NOVEL CHEMOTHERAPEUTIC AGENTS AGAINST INFLAMMATION AND CANCER | RELIANCE LIFE SCIENCES PVT. LTD. (IN) | 2010-07-01 | — | — | US | disclosed |
| EP-2081565-A2 | CINNAMIC ACID, VANILLIC ACID AND BENZOFURAN DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATION AND CANCER | Reliance Life Sciences Pvt., Ltd. (IN) | 2009-07-29 | — | — | EP | disclosed |
| WO-2008062466-A2 | CINNAMIC ACID, VANILLIC ACID AND BENZOFURAN DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATION AND CANCER | RELIANCE LIFE SCIENCES PVT. LTD. (IN) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168228-A1 | NOVEL CHEMOTHERAPEUTIC AGENTS AGAINST INFLAMMATION AND CANCER | NFKBIA, NFATC1, CHUK | TTR 4197/4885MET 1068/4885CA12 3736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.